HOME
LOGIN/REGISTER
THE MEDICAL LETTER
Subscribe
Current Issue
Previous Issues
Most Read Articles
ABOUT US
The Medical Letter, Inc.
CONTINUING EDUCATION
Exams
CONTACT US
The Medical Letter Mobile Home Page
CURRENT
ISSUE
1515
Auvi-Q (Kaléo; previously manufactured and marketed by Sanofi), the epinephrine auto-injector approved by the FDA in 2012 for emergency treatment of anaphylaxis and voluntarily withdrawn in 2015 due to potential inaccurate dosage delivery, has become available once more. According to Kaléo, improvements in the manufacturing process have addressed the concerns that led to its...  read more...
More from issue 1515
Coming Soon
Drugs for Hypertension
Bezlotoxumab (Zinplava) for Prevention of Recurrent Clostridium Difficile Infection
Plecanatide (Trulance) for Chronic Idiopathic Constipation
Previous Issues
© 2017 The Medical Letter, Inc.